Actual Medicinal Product (AMP) Zimovane LS 3.75mg tablets (Waymade Healthcare Plc)
Stability Information
(Some stability information inherited from generic)
- Stability
-
There are concerns about stability and/or there is a lack of stability data available. These medicines can theoretically be used in MCAs, although use is likely to be off-label. Mitigation measures may need to be considered. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or consider up to 8 weeks if the MCA is airtight (sealed). Consider the risk to the individual from potency loss or dose variability, particularly with unsealed devices. Monitor for any changes in therapeutic effect or increased adverse effects after MCA initiation.
- Notes
-
Protect from light. Protect from moisture. Max 28 days in MCA.
- Provenance
-
This compatibility recommendation is derived from Zimovane LS 3.75mg tablets (Sanofi) and Zopiclone 3.75mg tablets (Accord Healthcare Ltd).
- Generic
- Zopiclone
- Formulation
- Zopiclone 3.75mg tablets
-
Zopiclone
-
Zopiclone 3.75mg tablets
-
Zimovane LS 3.75mg tablets (Waymade Healthcare Plc)
-
-